Swedbank AB Buys 170,000 Shares of The Cooper Companies, Inc. $COO

Swedbank AB grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 18.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,074,029 shares of the medical device company’s stock after purchasing an additional 170,000 shares during the period. Swedbank AB’s holdings in Cooper Companies were worth $88,027,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Capital World Investors increased its stake in Cooper Companies by 25.7% during the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after acquiring an additional 2,159,233 shares during the period. State Street Corp lifted its position in shares of Cooper Companies by 1.2% in the 2nd quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock worth $616,227,000 after acquiring an additional 104,910 shares during the period. Wellington Management Group LLP lifted its position in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after acquiring an additional 4,756,178 shares during the period. Sustainable Growth Advisers LP grew its holdings in shares of Cooper Companies by 22.1% during the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after purchasing an additional 747,476 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of Cooper Companies by 98.8% during the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock valued at $241,120,000 after purchasing an additional 1,683,561 shares during the period. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on COO. Citigroup cut their target price on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research note on Friday, March 6th. Needham & Company LLC boosted their price target on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a report on Friday, March 6th. Barclays increased their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. William Blair raised shares of Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. Finally, Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Price Performance

Cooper Companies stock opened at $61.12 on Thursday. The business has a 50 day simple moving average of $71.63 and a 200 day simple moving average of $76.16. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company has a market capitalization of $11.93 billion, a PE ratio of 30.26, a price-to-earnings-growth ratio of 1.58 and a beta of 0.89. The Cooper Companies, Inc. has a one year low of $60.00 and a one year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.